Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
코스닥 제약기업의 연구개발투자와 소유구조 간의 관계
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 이문재 | - |
| dc.contributor.author | 최만규 | - |
| dc.date.accessioned | 2021-09-04T21:03:49Z | - |
| dc.date.available | 2021-09-04T21:03:49Z | - |
| dc.date.created | 2021-06-17 | - |
| dc.date.issued | 2015 | - |
| dc.identifier.issn | 1598-4877 | - |
| dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/95032 | - |
| dc.description.abstract | The purpose of this study is to analyze the influence of the financial structure of pharmaceutical companies on R&D investment. 358 pharmaceutical firms listed in the KOSDAQ market from 2000 to 2012. Financial statements and comments in general and internal transactions were extracted from TS-2000 of the Korea Listed Company Association (KLCA), and data related to stock price was extracted from KISVALUE-Ⅲ of NICE Information Service Co., Ltd. STATA 12.0 was used as the statistical package for panel analysis. The summary of the findings and the interpretation of the significance of this are as follows: First, the shareholding ratio of major shareholders and foreigners had a positive influence on R&D investment. Second, the ratio of outside directors had a negative influence on R&D investment. Third, the shareholding ratio of institutional investors did not have a significant influence on R&D investment. | - |
| dc.language | English | - |
| dc.language.iso | en | - |
| dc.publisher | 한국콘텐츠학회 | - |
| dc.title | 코스닥 제약기업의 연구개발투자와 소유구조 간의 관계 | - |
| dc.title.alternative | The Relationship between R&D investment and Ownership Structure in KOSDAQ Pharmaceutical Firms | - |
| dc.type | Article | - |
| dc.contributor.affiliatedAuthor | 최만규 | - |
| dc.identifier.doi | 10.5392/JKCA.2015.15.06.445 | - |
| dc.identifier.bibliographicCitation | 한국콘텐츠학회 논문지, v.15, no.6, pp.445 - 454 | - |
| dc.relation.isPartOf | 한국콘텐츠학회 논문지 | - |
| dc.citation.title | 한국콘텐츠학회 논문지 | - |
| dc.citation.volume | 15 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | 445 | - |
| dc.citation.endPage | 454 | - |
| dc.type.rims | ART | - |
| dc.identifier.kciid | ART002000924 | - |
| dc.description.journalClass | 2 | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordAuthor | Pharmaceutical Firms | - |
| dc.subject.keywordAuthor | R& | - |
| dc.subject.keywordAuthor | D Investment | - |
| dc.subject.keywordAuthor | Ownership Structure | - |
| dc.subject.keywordAuthor | Panel Study | - |
| dc.subject.keywordAuthor | KOSDAQ | - |
| dc.subject.keywordAuthor | 제약기업 | - |
| dc.subject.keywordAuthor | 연구개발투자 | - |
| dc.subject.keywordAuthor | 소유구조 | - |
| dc.subject.keywordAuthor | 패널연구 | - |
| dc.subject.keywordAuthor | 코스닥 | - |
- Files in This Item
- There are no files associated with this item.
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.